Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
+215K
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$5.6M
-
Number of buys
-
45
-
Number of sells
-
-42
-
Price
-
$27.10
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q4 2021
109 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q4 2021.
Replimune Group, Inc. - COMMON STOCK (REPL) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
of 78.4M outstanding shares and own 49.54% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.87M shares), Omega Fund Management, LLC (4.76M shares), Redmile Group, LLC (3.87M shares), Atlas Venture Life Science Advisors, LLC (3.21M shares), BlackRock Inc. (2.14M shares), VANGUARD GROUP INC (1.54M shares), STATE STREET CORP (1.25M shares), LOOMIS SAYLES & CO L P (1.11M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.08M shares), and Ensign Peak Advisors, Inc (1.07M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.